Key Takeaways An already approved drug might help kids with a rare bone cancerPazopanib extended survival in a small group of ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found ...

The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...

Autumn marks the start of respiratory virus season, when colds, flu and other bugs start circulating — especially among the ...

We do not know if other non-medicinal treatments and innovative healthcare support helped to reduce the number of seizures or improve children's quality of life because the evidence was limited and ...